Carl Zeiss Meditec Q1 revenue slightly up thanks to DORC integration

Carl Zeiss Meditec’s fiscal 2024/25 Q1 revenue amounted to €490.5 million, up by 3.3 percent at constant exchange rates versus 2023/24. However, quarterly sales declined by 7.3 percent year-on-year after adjusting for currency and acquisition effects, which the company said was expected.

Already an Eyewear Intelligence subscriber? Sign in here.

barrier_image_OIC

Subscribe today

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation
  • Organisation-wide access across offices, people and devices

To continue reading this article register now.